Capstone Investment Advisors LLC Acquires 13,525 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Capstone Investment Advisors LLC increased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVAFree Report) by 53.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,879 shares of the company’s stock after acquiring an additional 13,525 shares during the quarter. Capstone Investment Advisors LLC’s holdings in Privia Health Group were worth $895,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of PRVA. Victory Capital Management Inc. increased its position in Privia Health Group by 53.4% during the third quarter. Victory Capital Management Inc. now owns 24,014 shares of the company’s stock worth $552,000 after acquiring an additional 8,356 shares during the period. Illinois Municipal Retirement Fund bought a new position in Privia Health Group in the 3rd quarter valued at about $1,255,000. Barclays PLC increased its holdings in Privia Health Group by 24.4% in the 3rd quarter. Barclays PLC now owns 69,545 shares of the company’s stock valued at $1,600,000 after buying an additional 13,656 shares during the period. New York State Common Retirement Fund increased its holdings in Privia Health Group by 2.7% in the 3rd quarter. New York State Common Retirement Fund now owns 27,966 shares of the company’s stock valued at $643,000 after buying an additional 737 shares during the period. Finally, Great Lakes Advisors LLC bought a new position in Privia Health Group in the 3rd quarter valued at about $3,534,000. 94.48% of the stock is owned by institutional investors.

Insider Activity at Privia Health Group

In related news, EVP Thomas Bartrum sold 2,252 shares of the company’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $41,481.84. Following the completion of the transaction, the executive vice president now directly owns 103,862 shares in the company, valued at $1,913,138.04. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Privia Health Group news, Director Matthew Shawn Morris sold 11,059 shares of the stock in a transaction that occurred on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total value of $203,706.78. Following the transaction, the director now directly owns 70,101 shares in the company, valued at $1,291,260.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas Bartrum sold 2,252 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $41,481.84. Following the sale, the executive vice president now owns 103,862 shares in the company, valued at $1,913,138.04. The disclosure for this sale can be found here. In the last ninety days, insiders sold 49,390 shares of company stock worth $897,700. Corporate insiders own 14.20% of the company’s stock.

Wall Street Analysts Forecast Growth

PRVA has been the topic of several recent analyst reports. Stifel Nicolaus decreased their target price on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday, May 1st. Evercore ISI decreased their target price on shares of Privia Health Group from $26.00 to $25.00 and set an “outperform” rating on the stock in a report on Wednesday, February 28th. UBS Group decreased their target price on shares of Privia Health Group from $31.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, March 1st. Truist Financial reduced their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Wednesday, May 15th. Finally, Robert W. Baird began coverage on shares of Privia Health Group in a research note on Thursday. They issued an “outperform” rating and a $23.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. Based on data from MarketBeat.com, Privia Health Group currently has a consensus rating of “Moderate Buy” and an average price target of $24.92.

View Our Latest Stock Report on Privia Health Group

Privia Health Group Trading Up 5.2 %

PRVA traded up $0.86 during trading on Thursday, reaching $17.26. 952,005 shares of the company’s stock were exchanged, compared to its average volume of 990,963. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $29.42. The stock has a market capitalization of $2.06 billion, a PE ratio of 115.07, a price-to-earnings-growth ratio of 2.54 and a beta of 0.81. The firm has a fifty day moving average price of $18.13 and a two-hundred day moving average price of $20.49.

Privia Health Group (NASDAQ:PRVAGet Free Report) last posted its quarterly earnings data on Thursday, May 9th. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The firm had revenue of $415.24 million during the quarter, compared to the consensus estimate of $435.07 million. Sell-side analysts expect that Privia Health Group, Inc. will post 0.21 earnings per share for the current year.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Stories

Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVAFree Report).

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.